3.4.19.3	1,10-phenanthroline	weak activation	95283	
3.4.19.3	cyclosporin	increases particulate and soluble PAP activity in the renal cortex. Particulate PAP activity returns to levels similar to controls after 15 days of cyclosporin withdrawal, soluble PAP does not regress. Soluble and particulate aminopeptidases in resident and elicited macrophages are unaffected by cyclosporin	680172	
3.4.19.3	DFP	weak activation	95283	
3.4.19.3	dithiothreitol	-	678405, 682806	
3.4.19.3	dithiothreitol	absolute requirement for maintenance of activity	95301	
3.4.19.3	dithiothreitol	at least 10 mM required for full activity	681817	
3.4.19.3	dithiothreitol	presence of disulfide-reducing agent such as dithiothreitol required	95296	
3.4.19.3	dithiothreitol	rapid increase in activity from 2 to 6 mM, above this concentration plateau effect	681896	
3.4.19.3	dithiothreitol	strongly stimulates activity of wild-type enzyme and mutant enzyme C188S and shifts the pH-optimum to higher temperatures by about 10°C	651099	
3.4.19.3	DTT	enhances activity	653129	
3.4.19.3	EDTA	stimulates	95298	
3.4.19.3	EDTA	weak activation	95283	
3.4.19.3	glucose	alters the hypothalamic activity of soluble PAP-I	682252	
3.4.19.3	Insulin	alters the hypothalamic activity of soluble PAP-I	682252	
3.4.19.3	methanol	a methanol based deblocking solution preserves enzymatic activity, provides conditions compatible with sequencing and enhances deblocking of electroblotted samples	678405	
3.4.19.3	PMSF	weak activation	95283	
3.4.19.3	thio-reducing agent	absolute requirement	653759	
3.4.19.3	tris(2-carboxyethyl)phosphine	at least 0.5 mM required for full activity	681817